Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post a post on LinkedIn:
“ESMO Gynaecological Cancers
Copenhagen, Denmark | 17–19 June 2026
Honored to have been invited by ESMOgyn as discussant of Study-420 and MIROVA.
It was a privilege to contribute to the scientific discussion and exchange perspectives on the role of ADCs in platinum-eligible recurrent ovarian cancer.”
Other articles featuring Recurrent Ovarian Cancer on OncoDaily.
